Results 81 to 90 of about 13,758 (226)

Induction of anti-tumor immunity by trifunctional antibodies in patients with peritoneal carcinomatosis [PDF]

open access: yes, 2009
Peritoneal carcinomatosis (PC) from epithelial tumors is a fatal diagnosis without efficient treatment. Trifunctional antibodies (trAb) are novel therapeutic approaches leading to a concerted anti-tumor activity resulting in tumor cell destruction.
Michael A Ströhlein   +37 more
core   +3 more sources

Hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer

open access: yesJournal of Visceral Surgery, 2014
Ovarian cancer remains the fourth leading cause of cancer death in women in France. It is all too often diagnosed at an advanced stage with peritoneal carcinomatosis (PC), but remains confined to the peritoneal cavity throughout much of its natural history.
N, Bakrin   +5 more
openaire   +2 more sources

The role of cytokines in ovarian cancer drug resistance

open access: yesInternational Journal of Cancer, Volume 158, Issue 4, Page 821-834, 15 February 2026.
Abstract Ovarian cancer is the leading cause of death among women diagnosed with female reproductive system cancers. While significant advances have been made in treating various types of cancer, progress in ovarian cancer treatment over the past 20 years has been minimal, and the treatment course of ovarian cancer is not linear. Although many patients
Lu Wang   +7 more
wiley   +1 more source

Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy [PDF]

open access: yes, 2009
Background: Peritoneal tumor dissemination arising from colorectal cancer, appendiceal cancer, gastric cancer, gynecologic malignancies or peritoneal mesothelioma is a common sign of advanced tumor stage or disease recurrence and mostly associated with ...
Gabriel Glockzin   +2 more
core   +1 more source

Prognostic Factors and Nomogram‐Based Prediction Models for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis Undergoing Cytoreductive Surgery: A Retrospective Cohort Study

open access: yesCancer Medicine, Volume 15, Issue 1, January 2026.
ABSTRACT Background Colorectal cancer (CRC) with synchronous peritoneal metastasis (SPM) presents poor prognosis and complex treatment challenges. This study aimed to identify independent prognostic factors and develop nomogram‐based prediction models for overall survival (OS) and progression‐free survival (PFS) in CRC patients with SPM (CRC‐SPM ...
Xiaoxu Ge   +11 more
wiley   +1 more source

Hyperthermic Intraperitoneal Chemotherapy [PDF]

open access: yes, 2020
Yuranga Weerakkody   +2 more
openaire   +2 more sources

Successful Implementation of HITOC and HIPEC in the Management of Advanced Ovarian Carcinoma with Pleural and Peritoneal Carcinomatosis

open access: yesDiagnostics
This case report details the application and outcomes of a novel therapeutic approach involving hyperthermic intraperitoneal chemotherapy (HIPEC) and hyperthermic intrathoracic chemotherapy (HITOC) in a single patient diagnosed with advanced ovarian ...
Bogdan Moldovan   +11 more
doaj   +1 more source

Prospective case‐control cohort analysis of two‐day/two‐stage pelvic exenteration surgery: Safety, feasibility, acceptability and medium‐term outcomes

open access: yesColorectal Disease, Volume 28, Issue 1, January 2026.
Abstract Aim Pelvic exenteration (PE) is the only curative option for extensive pelvic cancers. Advances have facilitated increasingly complex resectional and reconstructive components, including per‐operative oncological adjuncts such as intraoperative radiotherapy.
Charles T. West   +8 more
wiley   +1 more source

Indigenous way of hyperthermic intraperitoneal chemotherapy

open access: yesJournal of Peritoneum (and other serosal surfaces), 2020
Introduction: Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a form of highly concentrated, heated chemotherapy that is delivered directly to the abdomen intra-operatively. Currently for peritoneal surface malignancy (PSM), either primary or secondary from gastrointestinal (GI) or gynecologic cancers, cytoreductive surgery (CRS) combined with ...
Rishin Dutta   +2 more
openaire   +1 more source

Desmoplastic Small Round Cell Tumor of the Abdomen: A Case Report

open access: yesCase Reports in Pathology, Volume 2026, Issue 1, 2026.
Background Desmoplastic small round cell tumor (DSRCT) is a rare and highly aggressive mesenchymal neoplasm that predominantly arises from the serosal surfaces of the peritoneum, most commonly affecting young males. Due to its rarity, overlapping histologic features with other small round blue cell tumors, and dependence on specialized ...
Ahmed Alsharakhat   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy